{"id":"https://openalex.org/W1596678070","doi":"https://doi.org/10.1046/j.1365-2125.2003.01785.x","title":"The pharmacokinetics of pioglitazone in patients with impaired renal function","display_name":"The pharmacokinetics of pioglitazone in patients with impaired renal function","alternate_titles":[],"publication_year":2003,"publication_date":"2003-04-01","ids":{"openalex":"https://openalex.org/W1596678070","doi":"https://doi.org/10.1046/j.1365-2125.2003.01785.x","mag":"1596678070","pmid":"https://pubmed.ncbi.nlm.nih.gov/12680885","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1884238"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2125.2003.01785.x","doi":"https://doi.org/10.1046/j.1365-2125.2003.01785.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-2125.2003.01785.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.2003.01785.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1596678070"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.2003.01785.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060425510","display_name":"Klemens Budde","orcid":"https://orcid.org/0000-0002-7929-5942","observed_orcids":["https://orcid.org/0000-0002-7929-5942"]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Klemens Budde","raw_affiliation_strings":["Department of Nephrology, University Hospital Charit\u00e9, Berlin, Germany","Department of Nephrology, University Hospital Charite, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology, University Hospital Charit\u00e9, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]},{"raw_affiliation_string":"Department of Nephrology, University Hospital Charite, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065115970","display_name":"Hans\u2010Hellmut Neumayer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hans\u2010Hellmut Neumayer","raw_affiliation_strings":["Department of Nephrology, University Hospital Charite, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology, University Hospital Charite, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111699907","display_name":"Lutz Fritsche","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lutz Fritsche","raw_affiliation_strings":["Department of Nephrology, University Hospital Charite, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology, University Hospital Charite, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080886481","display_name":"W\u0142adys\u0142aw Su\u0142owicz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126596746","display_name":"Jagiellonian University","ror":"https://ror.org/03bqmcz70","country_code":"PL","type":"education","lineage":["https://openalex.org/I126596746"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wladyslaw Sulowicz","raw_affiliation_strings":["Department of Nephrology, Jagiellonian University, Krako\u0301w, Poland, and","Department of Nephrology, Jagiellonian University, Krak\u00f3w, Poland, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology, Jagiellonian University, Krako\u0301w, Poland, and","institution_ids":["https://openalex.org/I126596746"]},{"raw_affiliation_string":"Department of Nephrology, Jagiellonian University, Krak\u00f3w, Poland, and","institution_ids":["https://openalex.org/I126596746"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045551258","display_name":"Tomasz P. Stomp\u00f3r","orcid":"https://orcid.org/0000-0002-3944-0850","observed_orcids":["https://orcid.org/0000-0002-3944-0850"]},"institutions":[{"id":"https://openalex.org/I126596746","display_name":"Jagiellonian University","ror":"https://ror.org/03bqmcz70","country_code":"PL","type":"education","lineage":["https://openalex.org/I126596746"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tomasz Stomp\u00f4r","raw_affiliation_strings":["Department of Nephrology, Jagiellonian University, Krako\u0301w, Poland, and","Department of Nephrology, Jagiellonian University, Krak\u00f3w, Poland, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology, Jagiellonian University, Krako\u0301w, Poland, and","institution_ids":["https://openalex.org/I126596746"]},{"raw_affiliation_string":"Department of Nephrology, Jagiellonian University, Krak\u00f3w, Poland, and","institution_ids":["https://openalex.org/I126596746"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090616052","display_name":"David Eckland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147578","display_name":"Takeda (United Kingdom)","ror":"https://ror.org/05c0v3585","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210147578","https://openalex.org/I44892455"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"David Eckland","raw_affiliation_strings":["Takeda Europe R&D Centre, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Europe R&D Centre, London, UK","institution_ids":["https://openalex.org/I4210147578"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5090616052"],"corresponding_institution_ids":["https://openalex.org/I4210147578"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":2.2272,"has_fulltext":true,"cited_by_count":148,"citation_normalized_percentile":{"value":0.88123897,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"55","issue":"4","first_page":"368","last_page":"374"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5073000192642212,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5073000192642212,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.3005000054836273,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.04179999977350235,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":1.0},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.8610000014305115},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9369999766349792},{"id":"https://openalex.org/keywords/drug-accumulation","display_name":"drug accumulation","score":0.6740000247955322},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.527999997138977},{"id":"https://openalex.org/keywords/creatinine-clearance","display_name":"creatinine clearance","score":0.5600000023841858},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.32899999618530273},{"id":"https://openalex.org/keywords/repeated-dosing","display_name":"repeated dosing","score":0.5270000100135803},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6230000257492065},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.8270000219345093},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.5260000228881836},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.44999998807907104},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.3619999885559082}],"concepts":[{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.9175255298614502},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8281204700469971},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.7434820532798767},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.698800802230835},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.592947244644165},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5372853875160217},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.5225229263305664},{"id":"https://openalex.org/C2908822073","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Impaired renal function","level":3,"score":0.506501317024231},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.4977872371673584},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.46604859828948975},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4571940004825592},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.1327531635761261},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.11395776271820068}],"mesh":[{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1046/j.1365-2125.2003.01785.x","doi":"https://doi.org/10.1046/j.1365-2125.2003.01785.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-2125.2003.01785.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.2003.01785.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1884238","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1884238/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:12680885","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12680885","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1046/j.1365-2125.2003.01785.x","doi":"https://doi.org/10.1046/j.1365-2125.2003.01785.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-2125.2003.01785.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.2003.01785.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1596678070.pdf","grobid_xml":"https://content.openalex.org/works/W1596678070.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W155803848","https://openalex.org/W999957181","https://openalex.org/W1979820286","https://openalex.org/W2003422043","https://openalex.org/W2015279471","https://openalex.org/W2027016046","https://openalex.org/W2034458926","https://openalex.org/W2068495554","https://openalex.org/W2075846250","https://openalex.org/W2089225574","https://openalex.org/W2114903378","https://openalex.org/W2123274543","https://openalex.org/W2302447233","https://openalex.org/W2337454357","https://openalex.org/W2339343999","https://openalex.org/W2408770126","https://openalex.org/W2409079576","https://openalex.org/W2417082936","https://openalex.org/W2438537620","https://openalex.org/W2609369491","https://openalex.org/W2769264260","https://openalex.org/W3192686273","https://openalex.org/W4210429559","https://openalex.org/W4297993310"],"related_works":["https://openalex.org/W2010396854","https://openalex.org/W2119158601","https://openalex.org/W2006239559","https://openalex.org/W2107589145","https://openalex.org/W4239703440","https://openalex.org/W2074796501","https://openalex.org/W1979820286","https://openalex.org/W2076152907","https://openalex.org/W2069759961"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"evaluate":[2],"the":[3,9,97,135,157],"effect":[4],"of":[5,13,78,86,116,138,227,292,308,315,329],"renal":[6,23,27,41,52,64,127,148,168,176,240,248,309,326],"impairment":[7,53,65,169,241],"on":[8],"pharmacokinetics":[10],"and":[11,15,19,25,59,74,88,92,99,105,122,144,208,273,289,317,331],"safety":[12,290],"pioglitazone":[14,79,87,117,139,179,251,293,316],"its":[16,89,119,318],"metabolites":[17,90,120,319],"M-III":[18,91,121,194,262],"M-IV":[20,93,123,209,274],"with":[21,39,50,62,126,142,145,166,171,174,238,243,246,305,324],"impaired":[22,147],"function":[24,42,177,249],"normal":[26,40,143,175,247],"function.":[28,149],"METHODS:":[29],"In":[30],"a":[31],"phase-I,":[32],"open-label,":[33],"parallel-group":[34],"study,":[35],"six":[36],"healthy":[37,172,244],"subjects":[38,141,173,245],"(creatinine":[43,54,66],"clearance>":[44],"80":[45],"ml":[46,57,70],"min-1),":[47],"nine":[48],"patients":[49,61,125,165,237,304,323,336],"moderate":[51],"clearance":[55,67],"30-60":[56],"min-1)":[58,71],"12":[60],"severe":[63,167,239,325],"<":[68],"30":[69],"received":[72],"single":[73,151],"multiple":[75],"oral":[76,152,225],"doses":[77,226,333],"45":[80],"mg.":[81],"The":[82,287],"serum":[83,313],"pharmacokinetic":[84,136],"profiles":[85],"were":[94,162,234],"assessed":[95],"for":[96,178,250],"first":[98],"last":[100],"dose":[101],"administered":[102],"(day":[103],"1":[104],"day":[106],"12,":[107],"respectively).":[108],"RESULTS:":[109],"Pharmacokinetic":[110],"data":[111],"revealed":[112],"no":[113,131],"significant":[114,132],"accumulation":[115],"or":[118],"in":[124,134,140,164,236,303,322,334],"impairment.":[128,310],"There":[129],"was":[130,294,300],"difference":[133],"profile":[137,291],"moderately":[146],"After":[150,223],"doses,":[153],"mean":[154,229,312],"area":[155],"under":[156],"concentration-time":[158],"curve":[159],"(AUC)":[160],"values":[161,231],"decreased":[163,235],"compared":[170,242],"(13":[180,196],"476":[181],"vs":[182,198,213,253,264,277],"17":[183],"387,":[184],"P":[185,201,216,255,266,280],"=":[186,202,217,256,267,281],"0.371;":[187],"-23%;":[188],"confidence":[189],"interval":[190],"(CI)":[191],"-57,":[192,260],"38),":[193],"metabolite":[195,210],"394":[197],"15":[199],"071,":[200],"0.841;":[203],"-11%;":[204],"CI":[205,220,259,270,284],"-74,":[206],"194)":[207],"(27":[211],"991":[212],"49":[214],"856,":[215],"0.006;":[218],"-44%;":[219],"-62,":[221],"-17).":[222],"repeated":[224],"pioglitazone,":[228],"AUC":[230],"(microg.h":[232],"l-1)":[233],"(8744":[252],"14,565,":[254],"0.004;":[257],"-40%;":[258],"-16),":[261],"(3991":[263],"7,289,":[265],"0.0009;":[268],"-45%;":[269],"-60,":[271],"-25)":[272],"(21":[275],"080":[276],"25":[278],"706,":[279],"0.181;":[282],"-18%;":[283],"39,":[285],"10).":[286],"tolerability":[288],"comparable":[295],"between":[296],"groups.":[297],"CONCLUSIONS:":[298],"Pioglitazone":[299],"well":[301],"tolerated":[302],"varying":[306],"degrees":[307],"Although":[311],"concentrations":[314],"are":[320],"increased":[321],"impairment,":[327],"adjustment":[328],"starting":[330],"maintenance":[332],"these":[335],"is":[337],"probably":[338],"unwarranted.":[339]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1596678070","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
